Загрузка...

Type 2 Diabetes Patients Reach Target Glycemic Control Faster Using IDegLira than Either Insulin Degludec or Liraglutide Given Alone

BACKGROUND AND OBJECTIVES: The time-course when changes in glycemic control and body weight were first manifest in patients with type 2 diabetes mellitus (T2DM) treated with a combination of insulin degludec and liraglutide (IDegLira) was assessed, comparing IDegLira to its individual components. ME...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Clin Drug Investig
Главные авторы: Vilsbøll, Tina, Vora, Jiten, Jarlov, Henrik, Kvist, Kajsa, Blonde, Lawrence
Формат: Artigo
Язык:Inglês
Опубликовано: Springer International Publishing 2016
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4801992/
https://ncbi.nlm.nih.gov/pubmed/26894800
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40261-016-0376-0
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!